Livento Group, Inc. (LIVG) stock: key figures, P/E, revenue and dividend
Information Technology · United States
Livento Group, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 151,388.00 USD |
| Gross profit | -2.05 m USD |
| Operating income | -13.92 m USD |
| EBIT | -12.32 m USD |
| Net income | -12.32 m USD |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Livento Group, Inc.
Livento Group, Inc., through its subsidiaries, engages in the film and television production business in the United States. The company is also involved in the real estate finance and development; artificial intelligence; and machine learning technology businesses. In addition, it provides Elisee, a software product that uses algorithms to read market data and neurological network abilities to determine the path forward and make ongoing corrections over time. Further, the company provides management services, such as budgeting, contract check and preparation project works, reporting and control of works, and analysis of available opportunities for acquisitions. The company was formerly known as NuGene International, Inc. and changed its name to Livento Group, Inc. in June 2022. Livento Group, Inc. is headquartered in New York, New York.
More stocks
- FiscalNote Holdings, Inc. (NOTE)
- Artificial Intelligence Technology Solutions Inc. (AITX)
- PAION (PA8.SG) (PA8.SG)
- One World Products, Inc. (OWPC)
- SmartKem, Inc. (SMTK)
- Onconetix, Inc. (ONCO)
- BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
- Metavesco, Inc. (MVCO)
- AI Era Corp. (AERA)
- Regen BioPharma Inc (RGBPP)
- Ocean Biomedical, Inc. (OCEA)
- Valion Bio, Inc. (VBIO)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.